Strategic Partnership Success TMS has an exclusive partnership with Neuronetics for NeuroStar Advanced Therapy, signaling a potential for bundled or co-marketed offerings and stronger credibility when approaching prospects seeking evidence-based TMS solutions.

Growth Potential As the world’s second largest TMS provider with 51-200 employees and $10M-$25M in revenue, Success TMS presents expansion opportunities into additional clinics or regional markets, particularly where payer coverage and patient access are improving.

Operational Leadership A seasoned executive in the COO role (Yvonne Diaz hired in 2021) indicates mature operations, scalable processes, and potential for cross-sell of value-added services to improve clinic efficiency and patient throughput.

Technology Enablement The tech stack emphasizes modern web presence and SEO, suggesting opportunities to offer digital marketing optimization, patient acquisition strategies, or telehealth-enabled patient engagement to boost referrals and scheduling.

Market Positioning FDA-approved, med-free TMS with broad insurance coverage, plus a proven faster relief timeline, provides a strong competitive angle for targeting payers, employers, and health systems seeking effective depression treatments with favorable cost and outcomes.